Carlyle, a private equity firm, is to expand its healthcare business with the acquisition of UK-based Abingworth LLP which has been providing venture capital to life science companies for decades. The transaction will combine Carlyle’s $301 billion of assets under management with the more than $2 billion in assets controlled by Abingworth. The financial terms of the deal were not disclosed.
